Evidence map›Paper›PMID 23395485›Full record

ReviewTrends in biotechnology2013

Genetic approaches to interfere with malaria transmission by vector mosquitoes.

Sibao Wang, Marcelo Jacobs-Lorena

Open access · greenAbstract readReview
In one paragraph

Review in Trends in biotechnology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
22.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 201 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Sibao WangKey Laboratory of Insect Developmental and Evolutionary Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China. sbwang@sibs.ac.cn
Marcelo Jacobs-Lorena
Chinese Academy of Sciences · CNJohns Hopkins University · US

Funding

Targeting mosquito organs with phage display librariesR01AI031478 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACOBS-LORENA, MARCELO · 1991 to 2018
$6.0M
Reducing malaria transmission with engineered bacteriaR21AI088033 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACOBS-LORENA, MARCELO, LAMPE, DAVID J · 2010 to 2011
$453k
NIAID NIH HHS R01 AI031478NIAID NIH HHS R21 AI088033
6 · The paper itself

Abstract

Malaria remains one of the most devastating diseases worldwide, causing over 1 million deaths every year. The most vulnerable stages of Plasmodium development in the vector mosquito occur in the midgut lumen, making the midgut a prime target for intervention. Mosquito transgenesis and paratransgenesis are two novel strategies that aim at rendering the vector incapable of sustaining Plasmodium development. Mosquito transgenesis involves direct genetic engineering of the mosquito itself for delivery of anti-Plasmodium effector molecules. Conversely, paratransgenesis involves the genetic modification of mosquito symbionts for expression of anti-pathogen effector molecules. Here we consider both genetic manipulation strategies for rendering mosquitoes refractory to Plasmodium infection, and discuss challenges for the translation of laboratory findings to field applications.

Indexed as

Microbial InteractionsAnimalsAnimals, Genetically ModifiedCulicidaeDisease Transmission, InfectiousDisease VectorsMalariaMosquito ControlPlasmodium

Identifiers

PMID23395485
PMCPMC3593784
OpenAlexW1971211810

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.